Surface Oncology, Inc. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales AgreementSurface Oncology, Inc. • May 22nd, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledMay 22nd, 2020 Industry JurisdictionSurface Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows: